| Popis: |
Splenectomy can treat conditions characterized by hemolysis or thrombocytopenia caused by autoantibodies or splenic reticuloendothelial function, as well as disorders characterized by massive splenomegaly and hypersplenism with cytopenias, such as hereditary spherocytosis, transfusion-dependent thalassemia, immune thrombocytopenia, autoimmune hemolytic anemia, splenic marginal zone lymph Splenectomy is no longer used for Hodgkin disease staging and is typically avoided in autoimmune lymphoproliferative syndrome, hereditary stomatocytosis or xerocytosis, cold agglutinin disease, paroxysmal cold hemoglobinuria, Gaucher disease, and cirrhosis-related hypersplenism. |
